Randy J. Levitt

730 total citations
8 papers, 521 citations indexed

About

Randy J. Levitt is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Randy J. Levitt has authored 8 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cancer Research. Recurrent topics in Randy J. Levitt's work include Growth Hormone and Insulin-like Growth Factors (3 papers), Estrogen and related hormone effects (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Randy J. Levitt is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (3 papers), Estrogen and related hormone effects (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Randy J. Levitt collaborates with scholars based in Canada, United Kingdom and United States. Randy J. Levitt's co-authors include Michaël Pollak, Donna Rindress, Hanane Khoury, Monika Wagner, Lonny J. Erickson, Mireille Goetghebeur, Maria-Magdalena Georgescu, Marie‐José Blouin, Yunhua Zhao and Maggie C.U. Cheang and has published in prestigious journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and Cancer Letters.

In The Last Decade

Randy J. Levitt

8 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randy J. Levitt Canada 8 229 126 116 82 76 8 521
Sophie Beale United Kingdom 17 209 0.9× 172 1.4× 88 0.8× 51 0.6× 286 3.8× 42 911
Meghan McDonald Canada 7 69 0.3× 173 1.4× 48 0.4× 113 1.4× 67 0.9× 13 878
Gisbert Selke Germany 10 202 0.9× 366 2.9× 46 0.4× 95 1.2× 277 3.6× 20 765
Pam S. Dellea United States 8 74 0.3× 59 0.5× 35 0.3× 68 0.8× 63 0.8× 11 438
Andrew S. Hyatt United States 14 93 0.4× 36 0.3× 42 0.4× 48 0.6× 49 0.6× 28 599
Prasad Bollina United Kingdom 11 36 0.2× 61 0.5× 42 0.4× 30 0.4× 91 1.2× 18 496
Monica Fujii United States 10 46 0.2× 103 0.8× 56 0.5× 106 1.3× 29 0.4× 28 561
Jie Jiang China 13 32 0.1× 116 0.9× 48 0.4× 71 0.9× 34 0.4× 82 613
Karen Hersey Canada 18 44 0.2× 202 1.6× 38 0.3× 186 2.3× 108 1.4× 45 1.1k
Thomas Michaeli Germany 13 240 1.0× 45 0.4× 25 0.2× 44 0.5× 19 0.3× 39 467

Countries citing papers authored by Randy J. Levitt

Since Specialization
Citations

This map shows the geographic impact of Randy J. Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy J. Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy J. Levitt more than expected).

Fields of papers citing papers by Randy J. Levitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy J. Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy J. Levitt. The network helps show where Randy J. Levitt may publish in the future.

Co-authorship network of co-authors of Randy J. Levitt

This figure shows the co-authorship network connecting the top 25 collaborators of Randy J. Levitt. A scholar is included among the top collaborators of Randy J. Levitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy J. Levitt. Randy J. Levitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lasko, Ben, et al.. (2012). Extended-release tramadol/paracetamol in moderate-to-severe pain: a randomized, placebo-controlled study in patients with acute low back pain. Current Medical Research and Opinion. 28(5). 847–857. 17 indexed citations
2.
Goetghebeur, Mireille, Monika Wagner, Hanane Khoury, et al.. (2011). Bridging Health Technology Assessment (HTA) and Efficient Health Care Decision Making with Multicriteria Decision Analysis (MCDA). Medical Decision Making. 32(2). 376–388. 126 indexed citations
3.
Goetghebeur, Mireille, Monika Wagner, Hanane Khoury, et al.. (2008). Evidence and Value: Impact on DEcisionMaking – the EVIDEM framework and potential applications. BMC Health Services Research. 8(1). 270–270. 169 indexed citations
4.
So, Alan, Randy J. Levitt, Bernhard J. Eigl, et al.. (2008). Insulin-Like Growth Factor Binding Protein-2 Is a Novel Therapeutic Target Associated with Breast Cancer. Clinical Cancer Research. 14(21). 6944–6954. 61 indexed citations
5.
Levitt, Randy J., Yunhua Zhao, Marie‐José Blouin, & Michaël Pollak. (2007). The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells. Cancer Letters. 255(2). 300–306. 28 indexed citations
6.
Levitt, Randy J., Maria-Magdalena Georgescu, & Michaël Pollak. (2005). PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2. Biochemical and Biophysical Research Communications. 336(4). 1056–1061. 54 indexed citations
7.
Levitt, Randy J., et al.. (2004). Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression. Biochemical and Biophysical Research Communications. 316(2). 421–428. 28 indexed citations
8.
Levitt, Randy J. & Michaël Pollak. (2002). Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.. PubMed. 62(24). 7372–6. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026